BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35324523)

  • 21. [Activation of HIF-1α/β-catenin signal pathway leads to radioresistance of prostate cancer cells].
    Luo Y; Li MC; Zhao JH; Han YL; Lin YH; Wang YX; Jiang YG; Lu Q; Lan L
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2552-2558. PubMed ID: 30220138
    [No Abstract]   [Full Text] [Related]  

  • 22. Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.
    Mitani T; Harada N; Nakano Y; Inui H; Yamaji R
    J Biol Chem; 2012 Sep; 287(40):33594-606. PubMed ID: 22865883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDGFRbeta and HIF-1alpha inhibition with imatinib and radioimmunotherapy of experimental prostate cancer.
    Kimura Y; Inoue K; Abe M; Nearman J; Baranowska-Kortylewicz J
    Cancer Biol Ther; 2007 Nov; 6(11):1763-72. PubMed ID: 17986854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer.
    Luo F; Lu FT; Cao JX; Ma WJ; Xia ZF; Zhan JH; Zeng KM; Huang Y; Zhao HY; Zhang L
    Cancer Lett; 2022 Apr; 531():39-56. PubMed ID: 35090965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
    Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
    J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
    Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
    Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
    Zhang J; Cao J; Weng Q; Wu R; Yan Y; Jing H; Zhu H; He Q; Yang B
    PLoS One; 2010 Nov; 5(11):e13910. PubMed ID: 21085474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
    Ding XC; Wang LL; Zhang XD; Xu JL; Li PF; Liang H; Zhang XB; Xie L; Zhou ZH; Yang J; Weichselbaum RR; Yu JM; Hu M
    J Hematol Oncol; 2021 Jun; 14(1):92. PubMed ID: 34118979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer.
    Jiang H; Feng Y
    Int J Gynecol Cancer; 2006; 16 Suppl 1():405-12. PubMed ID: 16515634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and implication of hypoxia inducible factor-1alpha in prostate neoplasm.
    Hao P; Chen X; Geng H; Gu L; Chen J; Lu G
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):593-5. PubMed ID: 15791851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
    Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1α inhibition.
    Chen B; Zhang M; Xing D; Feng Y
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28760843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
    Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
    Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.